BVF INC/IL - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXQ and the CUSIP is 686164302. A total of 53 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$108,000
-88.6%
534,900
-27.2%
0.01%
-90.4%
Q4 2017$948,000
-39.2%
734,9760.0%0.11%
-42.4%
Q3 2017$1,558,000
-26.9%
734,9760.0%0.20%
-40.2%
Q2 2017$2,131,000
-15.7%
734,9760.0%0.33%
-23.0%
Q1 2017$2,528,000
+97.7%
734,9760.0%0.43%
+67.3%
Q4 2016$1,279,000
-47.6%
734,9760.0%0.26%
-44.1%
Q3 2016$2,440,000734,9760.46%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 622,013$2,140,0000.92%
Foresite Capital Management III, LLC 380,530$1,309,0000.50%
BVF INC/IL 734,976$2,528,0000.43%
Old West Investment Management, LLC 206,687$711,0000.38%
Telemetry Investments, L.L.C. 88,269$304,0000.14%
EcoR1 Capital, LLC 117,726$405,0000.10%
Baupost Group 2,226,839$7,660,0000.09%
Rhenman & Partners Asset Management AB 120,000$413,0000.06%
GLG LLC 250,172$861,0000.05%
NEA Management Company, LLC 370,900$1,276,0000.04%
View complete list of OREXIGEN THERAPEUTICS INC shareholders